1. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Issue 22 (1st August 2022) Authors: Joffe, Johnathan K.; Cafferty, Fay H.; Murphy, Laura; Rustin, Gordon J.S.; Sohaib, Syed A.; Gabe, Rhian; Stenning, Sally P.; James, Elizabeth; Noor, Dipa; Wade, Simona; Schiavone, Francesca; Swift, Sarah; Dunwoodie, Elaine; Hall, Marcia; Sharma, Anand; Braybrooke, Jeremy; Shamash, Jonathan; Logue... Journal: Journal of clinical oncology Issue: Volume 40:Issue 22(2022) Page Start: 2468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study. (26th April 2016) Authors: Middleton, Mark R.; Dalle, Stéphane; Claveau, Joel; Mut, Pilar; Hallmeyer, Sigrun; Plantin, Patrice; Highley, Martin; Kotapati, Srividya; Le, Trong Kim; Brokaw, Jane; Abernethy, Amy P. Journal: Cancer medicine Issue: Volume 5:Number 7(2016:Jul.) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023) Authors: Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗